CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
Pig stem cells offer another approach to develop human organs for transplantation Kumar Jeetendra | December 18, 2020 In a new paper published in Stem Cell Reports, Bhanu Telugu and co-inventor Chi-Hun Park of the University of Maryland (UMD) Department of Animal and Avian Sciences show for the first time that newly generated stem cells from cows, when injected into embryos, contributed to the growth of only the organ of interest (the embryonic …
Novel platform has potential to detect many disease-related biomarkers in just one test Kumar Jeetendra | April 28, 2021 Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or …
“Genome Editing of Immune Cells” – New Lonza Virtual Event Kumar Jeetendra | September 14, 2022 Basel, Switzerland, 06 September 2022 – On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery. The 3-hour workshop brings together renowned genome editing experts from across industry and academia and comprises four interactive speaker sessions and a concluding panel discussion. …
